AI breast cancer screening study for women
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether artificial intelligence (AI) can improve breast cancer screening in women. It may help find cancer earlier and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 35 and 69 years old.
- You are taking part in a breast and cervical cancer screening program.
- You have never had breast cancer or any other cancer in the last 5 years.
- You do not have serious heart, lung, liver, or kidney disease that would shorten your life to less than 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a single radiologist reading your mammogram with help from artificial intelligence (AI) to the standard method of two radiologists reading it. The goal is to see if AI-assisted reading is just as good at finding cancer while saving time and resources.
This trial compares standard mammograms with mammograms aided by artificial intelligence (AI) to see if AI helps find breast cancer more accurately and reduces unnecessary callbacks. If you're 18 or older and getting a routine screening mammogram at one of the six participating health systems, you may be eligible.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This study tests whether artificial intelligence (AI) can help radiologists read mammograms (breast X-rays) more accurately during routine breast cancer screening. It aims to see if AI can catch more cancers early while reducing unnecessary follow-up exams.
This study uses an artificial intelligence (AI) model to analyze breast MRI images (non-contrast) to help detect breast cancer earlier. It's looking at whether the AI can find signs of cancer without needing a contrast dye injection.
This trial tests an AI tool that predicts genetic risk for breast cancer. It may help women identified as high-risk by their breast surgeon get quicker genetic counseling.
Hear when a new Breast Cancer Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.